» Articles » PMID: 10071245

In Serous Ovarian Neoplasms the Frequency of Ki-ras Mutations Correlates with Their Malignant Potential

Overview
Journal Virchows Arch
Date 1999 Mar 10
PMID 10071245
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

We analysed 44 tissue samples from serous ovarian neoplasms of different malignant potential for Ki-ras mutations by denaturing gradient gel electrophoresis (DGGE) and direct sequencing after microdissection. Point mutations at codon 12 were found in 7 of 20 tumours of low malignant potential (LMP) (35%) and in 2 of 6 well-differentiated carcinomas (33%). In contrast, no mutations were detected in the 11 poorly differentiated ovarian carcinoma samples or in the 7 serous cystadenomas. The frequency of Ki-ras mutations in serous ovarian tumours seems to correlate with the malignant potential of the neoplasms. The data favour the hypothesis of a de novo development of poorly differentiated ovarian carcinomas and do not support an evolution from LMP tumours or well-differentiated carcinomas.

Citing Articles

Establishment and characterization of a cell line and patient-derived xenograft (PDX) from peritoneal metastasis of low-grade serous ovarian carcinoma.

De Thaye E, Van de Vijver K, Van der Meulen J, Taminau J, Wagemans G, Denys H Sci Rep. 2020; 10(1):6688.

PMID: 32317693 PMC: 7174384. DOI: 10.1038/s41598-020-63738-6.


Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer.

Van Nieuwenhuysen E, Busschaert P, Laenen A, Moerman P, Han S, Neven P Neoplasia. 2019; 21(6):582-590.

PMID: 31054497 PMC: 6500912. DOI: 10.1016/j.neo.2019.03.014.


Tubal Origin of "Ovarian" Low-Grade Serous Carcinoma: A Gene Expression Profile Study.

Wang Y, Hong S, Mu J, Wang Y, Lea J, Kong B J Oncol. 2019; 2019:8659754.

PMID: 30949203 PMC: 6425354. DOI: 10.1155/2019/8659754.


The molecular pathology of ovarian serous borderline tumors.

Malpica A, Wong K Ann Oncol. 2016; 27 Suppl 1:i16-i19.

PMID: 27141064 PMC: 4852276. DOI: 10.1093/annonc/mdw089.


Tubal origin of ovarian low-grade serous carcinoma.

Chen C, Li J, Yao G, Chambers S, Zheng W Am J Clin Exp Obstet Gynecol. 2014; 1(1):13-36.

PMID: 25346935 PMC: 4205570.